Cardiff Oncology Inc. (CRDF) can’t be written off after posting last 3-months Average volume of 713.67K

Cardiff Oncology Inc. (CRDF) is priced at $5.44 after the most recent trading session. At the very opening of the session, the stock price was $7.32 and reached a high price of $7.71, prior to closing the session it reached the value of $7.04. The stock touched a low price of $7.01.

Cardiff Oncology Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.29 on 08/31/20, with the lowest value was $0.70 for the same time period, recorded on 03/19/20.

Cardiff Oncology Inc. (CRDF) full year performance was 274.47%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cardiff Oncology Inc. shares are logging -34.38% during the 52-week period from high price, and 676.03% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.70 and $8.29.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1194572 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Cardiff Oncology Inc. (CRDF) recorded performance in the market was 467.74%, having the revenues showcasing 119.31% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 161.64M, as it employees total of 14 workers.

Cardiff Oncology Inc. (CRDF) in the eye of market guru’s

During the last month, 0 analysts gave the Cardiff Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 3.87, with a change in the price was noted +5.07. In a similar fashion, Cardiff Oncology Inc. posted a movement of +538.68% for the period of last 100 days, recording 814,604 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRDF is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.

Cardiff Oncology Inc. (CRDF): Stocks Technical analysis and Trends

Raw Stochastic average of Cardiff Oncology Inc. in the period of last 50 days is set at 45.58%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 22.45%. In the last 20 days, the company’s Stochastic %K was 50.61% and its Stochastic %D was recorded 66.51%.

If we look into the earlier routines of Cardiff Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 467.74%. Additionally, trading for the stock in the period of the last six months notably improved by 429.32%, alongside a boost of 274.47% for the period of the last 12 months. The shares increased approximately by -6.01% in the 7-day charts and went down by 20.14% in the period of the last 30 days. Common stock shares were driven by 119.31% during last recorded quarter.